Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) — Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) is a clinical research site located in Las Vegas, Nevada, United States 89109.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has participated in 3 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Tumors With CDK4/6 Pathway Activation, Basal Cell Carcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2)?

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) conducted?

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has 3 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Tumors With CDK4/6 Pathway Activation, Basal Cell Carcinoma.

Is Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) accredited by Crixeo Health?

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.